BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33909795)

  • 21. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premalignant Gastric Lesions in Patients Included in National Colorectal Cancer Screening.
    Tepes B; Seruga M; Vujasinovic M; Urlep D; Ljepovic L; Brglez JN; Forte A; Anita Kek L; Skvarc M
    Radiol Oncol; 2018 Mar; 52(1):7-13. PubMed ID: 29520200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?
    Koivusalo AI; Pakarinen MP; Kolho KL
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Gastric and Colorectal Cancer Screening-A New Strategy.
    Selgrad M; Bornschein J; Kandulski A; Weigt J; Roessner A; Wex T; Malfertheiner P
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.
    Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Shakeri R; Persson EC; Islami F; Kamangar F; Abnet CC; Boffetta P; Engstrand L; Dawsey SM; Malekzadeh R; Ye W
    PLoS One; 2011; 6(10):e26957. PubMed ID: 22066020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
    Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
    J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune gastritis: assessment of OLGA and OLGIM staging systems.
    Ben Slama S; Ben Ghachem D; Dhaoui A; Ben Rejeb S; Jomni MT; Dougui MH; Bellil K
    Tunis Med; 2017 Apr; 95(4):262-267. PubMed ID: 29492930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Cheng HC; Tsai YC; Yang HB; Yeh YC; Chang WL; Kuo HY; Lu CC; Sheu BS
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28326664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
    Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
    Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia.
    Kurilovich S; Belkovets A; Reshetnikov O; Openko T; Malyutina S; Ragino Y; Scherbakova L; Leja M; Paloheimo L; Syrjänen K; Voevoda M
    Anticancer Res; 2016 Jan; 36(1):247-53. PubMed ID: 26722050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori Infection, Gastric Cancer and Gastropanel.
    Loor A; Dumitraşcu DL
    Rom J Intern Med; 2016 Sep; 54(3):151-156. PubMed ID: 27658162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Sivandzadeh GR; Zadeh Fard SA; Zahmatkesh A; Anbardar MH; Lankarani KB
    Middle East J Dig Dis; 2023 Jan; 15(1):37-44. PubMed ID: 37547155
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
    Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
    Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population based Helicobacter pylori screening and eradication: advances versus side effects.
    Tepes B
    Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
    Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
    Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
    Yue H; Shan L; Bin L
    Gastric Cancer; 2018 Jul; 21(4):579-587. PubMed ID: 29460004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Rugge M; Meggio A; Pravadelli C; Barbareschi M; Fassan M; Gentilini M; Zorzi M; Pretis G; Graham DY; Genta RM
    Gut; 2019 Jan; 68(1):11-17. PubMed ID: 29306868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.